General Information of MET (ID: META00215)
Name N-Acetylneuraminic acid
Synonyms   Click to Show/Hide Synonyms of This Metabolite
5-(acetylamino)-3,5-Dideoxy-D-glycero-D-galacto-2-nonulosonate; 5-(acetylamino)-3,5-Dideoxy-D-glycero-D-galacto-2-nonulosonic acid; 5-(acetylamino)-3,5-Dideoxy-D-glycero-b-D-galacto-2-nonulopyranosonate; 5-(acetylamino)-3,5-Dideoxy-D-glycero-b-D-galacto-2-nonulopyranosonic acid; 5-(acetylamino)-3,5-Dideoxy-delta-glycero-beta-delta-galacto-2-nonulopyranosonate; 5-(acetylamino)-3,5-Dideoxy-delta-glycero-beta-delta-galacto-2-nonulopyranosonic acid; 5-(acetylamino)-3,5-Dideoxy-delta-glycero-delta-galacto-2-nonulosonate; 5-(acetylamino)-3,5-Dideoxy-delta-glycero-delta-galacto-2-nonulosonic acid; 5-N-ACETYL-BETA-D-neuraminIC ACID; 5-N-ACETYL-b-D-neuraminate; 5-N-ACETYL-b-D-neuraminic acid; 5-N-Acetyl-D-neuraminate; 5-N-Acetyl-D-neuraminic acid; 5-N-Acetyl-beta-delta-neuraminic acid; 5-N-Acetyl-delta-neuraminate; 5-N-Acetyl-delta-neuraminic acid; 5-N-Acetylneuraminate; 5-N-Acetylneuraminic acid; 5-acetamido-3,5-Dideoxy-D-glycero-D-galacto-nonulosonate; 5-acetamido-3,5-Dideoxy-D-glycero-D-galacto-nonulosonic acid; 5-acetamido-3,5-Dideoxy-delta-glycero-delta-galacto-nonulosonate; 5-acetamido-3,5-Dideoxy-delta-glycero-delta-galacto-nonulosonic acid; Aceneuramate; Aceneuramic acid; Acetylneuraminate; Acetylneuraminic acid; Acid, N-acetylneuraminic; Acid, sialic; Lactaminate; Lactaminic acid; N Acetylneuraminic acid; N-Acetyl-D-neuraminate; N-Acetyl-D-neuraminic acid; N-Acetyl-b-D-neuraminate; N-Acetyl-b-D-neuraminic acid; N-Acetyl-b-neuraminate; N-Acetyl-beta-D-neuraminic acid; N-Acetyl-beta-delta-neuraminate; N-Acetyl-beta-delta-neuraminic acid; N-Acetyl-beta-neuraminate; N-Acetyl-delta-neuraminate; N-Acetyl-delta-neuraminic acid; N-Acetyl-neuraminate; N-Acetyl-neuraminic acid; N-Acetylneuramate; N-Acetylneuramic acid; N-Acetylneuraminate; N-Acetylneuraminic acid; N-Acetylsialate; N-Acetylsialic acid; NAN; NANA; Neu5ac; Sialic acid; b-5-acetamido-3,5-Dideoxy-D-glycero-D-galacto-nonulopyranosonate; b-5-acetamido-3,5-Dideoxy-D-glycero-D-galacto-nonulopyranosonic acid; b-Sialic acid; beta-5-acetamido-3,5-Dideoxy-delta-glycero-delta-galacto-nonulopyranosonate; beta-5-acetamido-3,5-Dideoxy-delta-glycero-delta-galacto-nonulopyranosonic acid; beta-Neu5ac; beta-Sialic acid
Source Endogenous;Escherichia Coli Metabolite;Food;Microbial
Structure Type   Carbohydrates and carbohydrate conjugates  (Click to Show/Hide the Complete Structure Type Hierarchy)
Organic oxygen compounds
Organooxygen compounds
Carbohydrates and carbohydrate conjugates
PubChem CID
445063
HMDB ID
HMDB0000230
Formula
C11H19NO9
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=445063"></iframe>
3D MOL 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
KEGG ID
C19910
DrugBank ID
DB04265
ChEBI ID
45744
ChemSpider ID
392810
Physicochemical Properties Molecular Weight 309.27 Topological Polar Surface Area 177
XlogP -3.5 Complexity 403
Heavy Atom Count 21 Rotatable Bond Count 5
Hydrogen Bond Donor Count 7 Hydrogen Bond Acceptor Count 9
Function
N-Acetylneuraminic acid (NeuAc) (CAS: 131-48-6), also known as sialic acid, is an acetyl derivative of the amino sugar neuraminic acid. It occurs in many glycoproteins, glycolipids, and polysaccharides in both mammals and bacteria. The most abundant sialic acid, NeuAc, is synthesized in vivo from N-acetylated D-mannosamine (ManNAc) or D-glucosamine (GlcNAc). NeuAc and its activated form, CMP-NeuAc, are biosynthesized in five consecutive reactions that form the intermediates UDP-N-acetylglucosamine (UDP-GlcNAc), N-acetylmannosamine (ManNAc), ManNAc 6-phosphate, NeuAc 9-phosphate, and CMP-NeuAc. CMP-NeuAc is transported into the Golgi apparatus and, with the aid of specific sialyltransferases, added onto nonreducing positions on oligosaccharide chains of glycoproteins and glycolipids. NeuAc is widely distributed throughout human tissues and found in several fluids, including serum, cerebrospinal fluid, saliva, urine, amniotic fluid, and breast milk. It is found in high levels in the brain, adrenal glands, and the heart. Serum and urine levels of the free acid are elevated in individuals suffering from renal failure. Serum and saliva Neu5Ac levels are also elevated in alcoholics. A genetic disorder known as Salla disease or infantile NeuAc storage disease is also characterized by high serum and urine levels of this compound. The negative charge is responsible for the slippery feel of saliva and mucins coating the body's organs. This particular sialic acid is known to act as a "decoy"" for invading pathogens. Along with involvement in preventing infections (mucus associated with mucous membranes mouth, nose, GI, respiratory tract), Neu5Ac acts as a receptor for influenza viruses, allowing attachment to mucous cells via hemagglutinin (an early step in acquiring influenzavirus infection). NeuAc is also becoming known as an agent necessary for mediating ganglioside distribution and structures in the brain. Sialic acid (SA) is an N-acetylated derivative of neuraminic acid that is an abundant terminal monosaccharide of glycoconjugates. Normal human serum SA is largely bound to glycoproteins or glycolipids (total sialic acid (TSA): 1.5-2.5 mmol/L), with small amounts of free SA (1-3 umol/L). Negatively charged SA units stabilize glycoprotein conformation in cell surface receptors to increase cell rigidity. This enables signal recognition and adhesion to ligands, antibodies, enzymes, and microbes. SA residues are antigenic determinant residues in carbohydrate chains of glycolipids and glycoproteins, chemical messengers in tissue and body fluids, and may regulate glomeruli basement membrane permeability. Sialic acids are structurally unique nine-carbon keto sugars occupying the interface between the host and commensal or pathogenic microorganisms. An important function of host sialic acid is to regulate innate immunity. Sialic acid is the moiety most actively recycled for metabolic purposes in the salvage pathways in glycosphingolipid metabolism. Sialic acid is indispensable for the neuritogenic activities of ganglioside constituents which are unique in that a sialic acid directly binds to the glucose of the cerebroside, they are mutually connected in tandem, and some are located in the internal parts of the sugar chain. Sialylation (sialic acid linked to galactose, N-acetylgalactosamine, or another sialic acid) represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      Hydrolases (EC 3)
            Alpha-N-acetylglucosaminidase (NAGLU) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Knockout of Naglu
                      Induced Change N-Acetylneuraminic acid concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Lysosomal storage diseases [ICD-11: 5C56]
                      Details It is reported that knockout of Naglu leads to the decrease of N-acetylneuraminic acid levels compared with control group.
            N-acylneuraminate-9-phosphatase (NANP) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockout of NANP
                      Induced Change N-Acetylneuraminic acid concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Carbohydrate metabolism disorders [ICD-11: 5C51]
                      Details It is reported that knockout of NANP leads to the decrease of N-acetylneuraminic acid levels compared with control group.
      Lyases (EC 4)
            Cystathionine gamma-lyase (CTH) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [3]
                      Introduced Variation Knockout of Cth
                      Induced Change N-Acetylneuraminic acid concentration: increase (FC = 2.05)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Organic acid disorderss [ICD-11: 5C50]
                      Details It is reported that knockout of Cth leads to the increase of N-acetylneuraminic acid levels compared with control group.
      Pore-forming PNC peptide (PNC)
            Cellular tumor antigen p53 (TP53) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [4]
                      Introduced Variation Knockout of TP53
                      Induced Change N-Acetylneuraminic acid concentration: decrease (Log2 FC=0.66)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Colon cancer [ICD-11: 2B90]
                      Details It is reported that knockout of TP53 leads to the decrease of N-acetylneuraminic acid levels compared with control group.
      Transferases (EC 2)
            Acetylglucosaminyltransferase 5 (MGAT5) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [5]
                      Introduced Variation Knockout of Mgat5
                      Induced Change N-Acetylneuraminic acid concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockout of Mgat5 leads to the decrease of N-acetylneuraminic acid levels compared with control group.
            N-acylneuraminate cytidylyltransferase (CMAS) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [6]
                      Introduced Variation Knockout of CMAS
                      Induced Change N-Acetylneuraminic acid concentration: increase (FC = 30)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockout of CMAS leads to the increase of N-acetylneuraminic acid levels compared with control group.
References
1 Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery. Mol Ther. 2017 Mar 1;25(3):792-802.
2 Activity of N-acylneuraminate-9-phosphatase (NANP) is not essential for de novo sialic acid biosynthesis. Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1471-1479.
3 Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes. Oxid Med Cell Longev. 2021 Feb 13;2021:8877691.
4 Integrative omics analysis of p53-dependent regulation of metabolism. FEBS Lett. 2018 Feb;592(3):380-393.
5 N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway. J Biol Chem. 2014 Jun 6;289(23):15927-41.
6 Sialylation Is Dispensable for Early Murine Embryonic Development in Vitro. Chembiochem. 2017 Jul 4;18(13):1305-1316.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.